Spotlight -

Long-Acting Injectable Therapy in the Management of Adult Patients with Schizophrenia|

Major Depressive Disorder

Paras Gupta, MBE

Articles by Paras Gupta, MBE

Ktsdesign/AdobeStock

The Impact of Selective Serotonin Reuptake Inhibitors on Bleeding Risk: A Comprehensive Review

ByParas Gupta, MBE,Sarah Hakam, BS,Arsalan Nisar, MS,Inna D'Empaire, MD,Gina Jamal, MD,Reza Safavi, MD

February 3rd 2025

What patients are at risk when taking SSRIs?

Latest Updated Articles

The Impact of Selective Serotonin Reuptake Inhibitors on Bleeding Risk: A Comprehensive Review
February 3rd 2025

Trending on Psychiatric Times

Neuropsychiatry in the News: Wearable Technology for Parkinson Disease, Ecopipam for Tourette Syndrome

Psyched Perspectives: ADHD in Underrecognized Populations, With Paige Walton, MD

FDA Feedback Paves Way for New IND Filing for PT00114 in Generalized Anxiety Disorder

Let’s Talk About Drug Testing

HLP003, Deuterated Psilocin, as an Adjunctive Therapy for Major Depressive Disorder